Palvella Therapeutics, Inc. (PVLA)

Profile

Full Name

Palvella Therapeutics, Inc.

Ticker

NASDAQ: PVLA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 2, 2015

Indexes

Not included

Website

https://palvellatx.com

Employees

14

Key Details

Price

$56.57(+3.78%)

Market cap

$625.65M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$7.83(-104.51% YoY)

PE ratio

-

Next earnings date

Nov 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $56.57
    PVLA price is $56.57

    30-Day Relative Volume

    1.84
    PVLA 30-day relative volume is 1.84

    Price Performance

    Price Most recent change

    +3.78%
    PVLA price was up +3.78% on Sep 17, 2025

    Price YTD change

    +371.42%
    PVLA price is up +371.42% since January 1st

    Price 1-year change

    +250.06%
    PVLA price is up +250.06% year-on-year

    Price 3-year change

    -47.23%
    PVLA price is down -47.23% over the past 3 years

    Price Range

    Price All-time high

    $780.00
    PVLA price is currently -92.75% below its historical high of $780.00

    Price 3-year low

    $6.20
    PVLA price is currently +812.42% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $625.65M
    PVLA market capitalization is $625.65 million

    Market cap 3-year change

    +527.49%
    PVLA market capitalization is up +527.49% over the past 3 years

    Market cap All-time high

    $660.60M
    PVLA market capitalization is currently -5.29% below its historical high of $660.60 million

    Market cap sector rank

    66.61%
    PVLA market capitalization is higher than 66.61% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +737.73%
    PVLA shares outstanding is up +737.73% year-on-year

    Shares Outstanding 3-Year Change

    +1089.09%
    PVLA shares outstanding is up +1089.09% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.67
    PVLA beta is 0.67

    200-day SMA

    $26.30
    PVLA price is currently +115.10% above its 200-day simple moving average

    50-day SMA

    $44.00
    PVLA price is currently +28.58% above its 50-day simple moving average

    RSI

    61.71
    PVLA 14-day relative strength index is 61.71

    Volume

    1.84
    PVLA 30-day relative volume is 1.84

    ATR

    $3.61
    PVLA average true range is $3.61

    10-day Historical Volatility

    49.27%
    PVLA 10-day historical volatility is 49.27%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    PVLA annual revenue is $0.00

    Revenue Analysts estimate

    -
    PVLA annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    PVLA annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    PVLA annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$7.83
    PVLA annual earnings per share is -$7.83

    EPS Analysts estimate

    -$3.27
    PVLA annual earnings per share is currently +139.32% higher than the consensus analysts' forecast

    EPS 1-year change

    -104.51%
    PVLA annual earnings per share is down -104.51% year-on-year

    EPS Sector rank

    14.95%
    PVLA annual earnings per share is higher than 14.95% of companies in Healthcare sector

    Profit

    Gross profit

    $0.00
    PVLA annual gross profit is $0.00

    Gross margin

    -
    PVLA annual gross profit margin value is unknown

    Operating profit

    -$14.10M
    PVLA annual operating income is -$14.10 million

    Operating margin

    -
    PVLA annual operating profit margin value is unknown

    Net income

    -$17.43M
    PVLA annual net profit is -$17.43 million

    Net margin

    -
    PVLA annual net profit margin value is unknown

    Expenses

    Total expenses

    $17.43M
    PVLA annual total expenses is $17.43 million

    Operating expenses

    $14.10M
    PVLA annual total operating expenses is $14.10 million

    Cost of goods sold

    $0.00
    PVLA annual cost of goods sold is $0.00

    Selling, general & administrative expenses

    $0.00
    PVLA annual SGA is $0.00

    Depreciation and amortization

    -
    PVLA annual depreciation & amortization value is unknown

    Interest expense

    $0.00
    PVLA annual interest expense is $0.00

    Income tax

    $0.00
    PVLA annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$14.10M
    PVLA annual earnings before interest & taxes is -$14.10 million

    EBITDA

    -$14.10M
    PVLA annual EBITDA is -$14.10 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $88.23M
    PVLA annual total assets is $88.23 million

    Non current assets

    $0.00
    PVLA annual long term assets is $0.00

    Current assets

    $88.23M
    PVLA annual total current assets is $88.23 million

    Cash and cash equivalents

    $83.60M
    PVLA annual cash & cash equivalents is $83.60 million

    Accounts receivable

    $358.00K
    PVLA annual accounts receivable is $358.00 thousand

    Inventory

    $0.00
    PVLA annual inventory is $0.00

    Liabilities

    Total liabilities

    $25.63M
    PVLA annual total liabilities is $25.63 million

    Long term liabilities

    $13.59M
    PVLA annual total long term liabilities is $13.59 million

    Current liabilities

    $12.04M
    PVLA annual total current liabilities is $12.04 million

    Accounts payable

    $4.59M
    PVLA annual accounts payable is $4.59 million

    Debt

    Total debt

    $11.94M
    PVLA annual total debt is $11.94 million

    Total debt 1-year change

    -84.82%
    PVLA annual total debt is down -84.82% year-on-year

    Long term debt

    $11.94M
    PVLA annual long term debt is $11.94 million

    Short term debt

    $0.00
    PVLA annual short term debt is $0.00

    Equity & Capital

    Shareholders equity

    $62.61M
    PVLA annual stockholders equity is $62.61 million

    Book value

    $62.61M
    PVLA annual book value is $62.61 million

    Retained earnings

    -$93.73M
    PVLA annual retained earnings is -$93.73 million

    Working capital

    $76.20M
    PVLA annual working capital is $76.20 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$10.84M
    PVLA annual cash flow from operations is -$10.84 million

    Cash from operations 1-year change

    +20.89%
    PVLA annual cash flow from operations is up +20.89% year-on-year

    Cash from investing

    $0.00
    PVLA annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    0%
    PVLA annual cash flow from investing activities has remained unchanged year-on-year

    Cash from financing

    $87.09M
    PVLA annual cash flow from financing activities is $87.09 million

    Cash from financing 1-year change

    +1641.78%
    PVLA annual cash flow from financing activities is up +1641.78% year-on-year

    CAPEX

    CAPEX

    $0.00
    PVLA annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    PVLA annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$10.84M
    PVLA annual free cash flow is -$10.84 million

    Free cash flow 1-year change

    +20.89%
    PVLA annual free cash flow is up +20.89% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    PVLA annual gross profit margin value is unknown

    Operating margin

    -
    PVLA annual operating profit margin value is unknown

    Net margin

    -
    PVLA annual net profit margin value is unknown

    ROA & ROE

    ROA

    -36.40%
    PVLA annual return on assets is -36.40%

    ROE

    -27.85%
    PVLA annual return on equity is -27.85%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    PVLA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    PVLA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    13.09
    PVLA price to book ratio is 13.09

    PB ratio Sector rank

    91.51%
    PVLA price to book ratio is higher than 91.51% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    PVLA price to sales ratio value is unknown

    PS ratio Sector rank

    -
    PVLA price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $569.73M
    PVLA enterprise value is $569.73 million

    Enterprise value Sector rank

    67.34%
    PVLA enterprise value is higher than 67.34% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -28.13
    PVLA EV/EBITDA is -28.13

    EV/EBITDA Sector rank

    5.2%
    PVLA EV/EBITDA is higher than 5.2% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.33
    PVLA annual current ratio is 7.33

    Quick ratio

    7.33
    PVLA annual quick ratio is 7.33

    Leverage

    Debt to equity

    0.19
    PVLA annual debt to equity ratio is 0.19

    Interest coverage ratio

    -
    PVLA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    PVLA piotroski f-score value is unknown

    Altman Z-Score

    13.67
    PVLA altman z-score is 13.67

    Analyst ratings

    Recent major analysts updates

    Sep 9, 25 Oppenheimer
    Outperform
    Aug 19, 25 Canaccord Genuity
    Buy
    Aug 15, 25 HC Wainwright & Co.
    Buy
    Aug 15, 25 Chardan Capital
    Buy
    Aug 6, 25 Raymond James
    Outperform
    Aug 4, 25 LifeSci Capital
    Outperform
    Jul 21, 25 Truist Securities
    Buy
    May 16, 25 Canaccord Genuity
    Buy
    Apr 30, 25 HC Wainwright & Co.
    Buy
    Apr 9, 25 Chardan Capital
    Buy

    Institutional Ownership

    Screeners with PVLA included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Palvella Therapeutics, Inc.?
    • Does Palvella Therapeutics, Inc. pay dividends?
    • What sector is Palvella Therapeutics, Inc. in?
    • What industry is Palvella Therapeutics, Inc. in?
    • What country is Palvella Therapeutics, Inc. based in?
    • When did Palvella Therapeutics, Inc. go public?
    • Is Palvella Therapeutics, Inc. in the S&P 500?
    • Is Palvella Therapeutics, Inc. in the NASDAQ 100?
    • Is Palvella Therapeutics, Inc. in the Dow Jones?
    • When was Palvella Therapeutics, Inc.'s last earnings report?
    • When does Palvella Therapeutics, Inc. report earnings?

    What is the ticker symbol for Palvella Therapeutics, Inc.?

    The ticker symbol for Palvella Therapeutics, Inc. is NASDAQ:PVLA

    Does Palvella Therapeutics, Inc. pay dividends?

    No, Palvella Therapeutics, Inc. does not pay dividends

    What sector is Palvella Therapeutics, Inc. in?

    Palvella Therapeutics, Inc. is in the Healthcare sector

    What industry is Palvella Therapeutics, Inc. in?

    Palvella Therapeutics, Inc. is in the Biotechnology industry

    What country is Palvella Therapeutics, Inc. based in?

    Palvella Therapeutics, Inc. is headquartered in United States

    When did Palvella Therapeutics, Inc. go public?

    Palvella Therapeutics, Inc.'s initial public offering (IPO) was on January 2, 2015

    Is Palvella Therapeutics, Inc. in the S&P 500?

    No, Palvella Therapeutics, Inc. is not included in the S&P 500 index

    Is Palvella Therapeutics, Inc. in the NASDAQ 100?

    No, Palvella Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Palvella Therapeutics, Inc. in the Dow Jones?

    No, Palvella Therapeutics, Inc. is not included in the Dow Jones index

    When was Palvella Therapeutics, Inc.'s last earnings report?

    Palvella Therapeutics, Inc.'s most recent earnings report was on August 14, 2025

    When does Palvella Therapeutics, Inc. report earnings?

    The next expected earnings date for Palvella Therapeutics, Inc. is November 13, 2025
    On this page